太极集团股价下跌1.07% 上半年净利润同比下滑71.94%

Group 1 - The stock price of Taiji Group is reported at 23.21 yuan, down 0.25 yuan or 1.07% from the previous trading day, with a trading volume of 136,551 hands and a transaction amount of 319 million yuan [1] - Taiji Group is primarily engaged in the research, development, production, and sales of traditional Chinese medicine, chemical drugs, and biopharmaceuticals, covering various therapeutic areas including digestive, respiratory, cardiovascular, and anti-infection [1] - The company disclosed its semi-annual report for 2025, showing a revenue of 5.658 billion yuan, a year-on-year decrease of 27.63%, and a net profit attributable to shareholders of 139 million yuan, down 71.94% year-on-year, mainly due to policy impacts and inventory digestion of certain products [1] Group 2 - The company announced plans to publicly transfer a vacant property in Chengdu with an assessed value of 39.136 million yuan [1] - In terms of capital flow, Taiji Group experienced a net outflow of 30.6396 million yuan on the day, with a cumulative net outflow of 237.7444 million yuan over the past five days [1]